Your browser doesn't support javascript.
loading
Urinary-based tumor markers enhance microhematuria risk stratification according to baseline bladder cancer prevalence.
Woldu, Solomon L; Souter, Lesley; Boorjian, Stephen A; Barocas, Daniel A; Lotan, Yair.
Affiliation
  • Woldu SL; Department of Urology, University of Texas Southwestern Medical Center Dallas, Dallas, TX.
  • Souter L; Nomadic EBM Methodology.
  • Boorjian SA; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Barocas DA; Department of Urology, Vanderbilt University Medical Center, Nashville, TN.
  • Lotan Y; Department of Urology, University of Texas Southwestern Medical Center Dallas, Dallas, TX. Electronic address: Yair.Lotan@UTSouthwestern.edu.
Urol Oncol ; 39(11): 787.e1-787.e7, 2021 11.
Article in En | MEDLINE | ID: mdl-33858747

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Hematuria Type of study: Etiology_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Male Language: En Journal: Urol Oncol Journal subject: NEOPLASIAS / UROLOGIA Year: 2021 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Hematuria Type of study: Etiology_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Male Language: En Journal: Urol Oncol Journal subject: NEOPLASIAS / UROLOGIA Year: 2021 Document type: Article Country of publication: United States